Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
NCT02079246
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1463
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
Idalopirdine 60 mg
Sponsor
H. Lundbeck A/S